These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19886073)

  • 1. Bowel lesions in spondyloarthritides.
    Rimbaş M; Marinescu M; Voiosu MR
    Rom J Intern Med; 2009; 47(1):75-85. PubMed ID: 19886073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
    Mielants H; Veys EM
    Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2273-8. PubMed ID: 8835561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Gyselbrecht L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2279-84. PubMed ID: 8835562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy insight: how the gut talks to the joints--inflammatory bowel disease and the spondyloarthropathies.
    Meier C; Plevy S
    Nat Clin Pract Rheumatol; 2007 Nov; 3(11):667-74. PubMed ID: 17968338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease.
    Mielants H; De Vos M; Goemaere S; Schelstraete K; Cuvelier C; Goethals K; Maertens M; Ackerman C; Veys EM
    J Rheumatol; 1991 Mar; 18(3):394-400. PubMed ID: 1906939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: joint involvement in inflammatory bowel disease.
    De Vos M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():36-42. PubMed ID: 15352892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut and spondyloarthropathies.
    Leirisalo-Repo M; Repo H
    Rheum Dis Clin North Am; 1992 Feb; 18(1):23-35. PubMed ID: 1561404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to optimize the antiTNF alpha therapy in spondylitis?].
    Castro Villegas Mdel C; Escudero Contreras A; Miranda García MD; Collantes Estévez E
    Reumatol Clin; 2012 Mar; 8 Suppl 1():S26-31. PubMed ID: 22418285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of gut inflammation in the pathogenesis of spondyloarthropathies.
    Mielants H; De Vos M; Cuvelier C; Veys EM
    Acta Clin Belg; 1996; 51(5):340-9. PubMed ID: 8950841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spondyloarthritis and inflammatory bowel disease. Comorbidity and treatment implications.
    Varkas G; Van Praet L; Cypers H; Elewaut D
    Z Rheumatol; 2013 Aug; 72(6):524-9. PubMed ID: 23756592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
    Beaugerie L; Sokol H; Seksik P
    Dig Dis; 2009; 27(3):375-81. PubMed ID: 19786768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel development in extraintestinal manifestations and spondylarthropathy.
    De Vos M; Hindryckx P; Laukens D
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S19-26. PubMed ID: 21640926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease.
    Karimi O; Peña AS
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S136-41. PubMed ID: 18806706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of the gut/joint axis for the management of spondyloarthritis in daily clinical practice.
    Cypers H; Van Praet L; Varkas G; Elewaut D
    Curr Opin Rheumatol; 2014 Jul; 26(4):371-6. PubMed ID: 24841232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal disorders in rheumatic diseases.
    Parke AL
    Curr Opin Rheumatol; 1992 Feb; 4(1):68-75. PubMed ID: 1543665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease.
    Marks DJ; Miyagi K; Rahman FZ; Novelli M; Bloom SL; Segal AW
    Am J Gastroenterol; 2009 Jan; 104(1):117-24. PubMed ID: 19098859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-steroidal anti-inflammatory drugs and lower intestinal tract toxicity].
    Bogas M; Afonso Mdo C; Araújo D
    Acta Reumatol Port; 2006; 31(3):227-35. PubMed ID: 17094334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications.
    Lanas A; Sopeña F
    Gastroenterol Clin North Am; 2009 Jun; 38(2):333-52. PubMed ID: 19446262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating the pathogenesis of spondyloarthritis: gut and joint united?
    De Wilde K; Debusschere K; Beeckman S; Jacques P; Elewaut D
    Curr Opin Rheumatol; 2015 Mar; 27(2):189-96. PubMed ID: 25588139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.